BIO
Bio-Rad Laboratories
$368.75
−$8.22 (−2.18%)Sep 10, 2026
Key metrics
The numbers that frame BIO today
- Market cap
- $9.86B
- P/E (TTM)
- 44.3
- EV / FCF
- 30.3
- Gross margin
- 51.9%
- EV / Sales
- 4.1
- ROIC
- 4.2%
- Div yield
- 0%
- Debt / equity
- 0.2
- 52wk Low
- $236.73
- 52wk High
- $396.23
Growth
Revenue and earnings trend for BIO
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about BIO
Is Bio-Rad Laboratories a good buy?
Yes. Bio-Rad Laboratories has mixed quality and excellent momentum. Taken together, the setup leans positive. Growth looks strong, which supports the long-term business case. We think Bio-Rad Laboratories is selling at a fair price.
What is the market capitalization of BIO?
Bio-Rad Laboratories's market capitalization is $9.86B.
What is the P/E ratio for BIO stock?
Bio-Rad Laboratories's current P/E ratio is 44.3.
What is the 52-week high for BIO stock?
The 52-week high for Bio-Rad Laboratories is $396.23. The current close of $368.75 is 6.9% below that high.
What is the 52-week low for BIO stock?
The 52-week low for Bio-Rad Laboratories is $236.73. The current close of $368.75 is 55.8% above that low.
Does BIO stock pay dividends?
Bio-Rad Laboratories does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for BIO?
Bio-Rad Laboratories's Debt / Equity ratio is 0.19.